Search
Puromycin
go.drugbank.com/drugs/DB08437ExperimentalPuromycin is toxic to both prokaryotic and eukaryotic cells, resulting in significant cell death at appropriate doses.
Glycochenodeoxycholic Acid
go.drugbank.com/drugs/DB02123ExperimentalIt acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. [PubChem]
Categories: N-substituted GlycinesAD-233B
go.drugbank.com/drugs/DB33953ExperimentalAD-233B is under investigation in clinical trial NCT07816198 (A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy).
Eptazocine
go.drugbank.com/drugs/DB19670ExperimentalThe usage of the INN stem '-azocine' in the name indicates that Eptazocine is a narcotic antagonist/agonist related to 6,7-benzomorphan. Eptazocine has a monoisotopic molecular weight of 231.16 Da.
Abitesartan
go.drugbank.com/drugs/DB19863ExperimentalThe usage of the INN stem '-sartan' in the name indicates that Abitesartan is a angiotensin II receptor antagonist, antihypertensive (non-peptidic).
Alacepril
go.drugbank.com/drugs/DB21364ExperimentalAlacepril is a small molecule drug. The usage of the INN stem '-pril' in the name indicates that Alacepril is a angiotensin-converting enzyme inhibitor. Alacepril has a monoisotopic molecular weight of 406.16 Da.
Categories: Agents Acting on the Renin-Angiotensin SystemHuman interleukin-2
go.drugbank.com/drugs/DB14865InvestigationalHuman interleukin-2 is under investigation in clinical trial NCT03475134 (TIL-ACT After NMA Chemo With IL-2 and Nivo Rescue in mMEL).
Categories: Analgesics, Non-NarcoticARG201
go.drugbank.com/drugs/DB06621ExperimentalARG201, a bovine-derived Type I collagen, aims to induce immune tolerance in patients with Diffuse Systemic Scleroderma (dcSSc).
CERE-120
go.drugbank.com/drugs/DB05637InvestigationalCERE-120 is an investigational drug consisting of an adeno-associated virus (AAV) that was engineered to carry the human gene for neurturin, a neurotrophic (growth) factor.
Escin
go.drugbank.com/drugs/DB15907InvestigationalSodium aescinate is under investigation in clinical trials for its potential to treat cerebral conditions, including NCT04247659 (studying the relationship between asymmetric vascular sign of cortex and